Showing results (241-250 of 34,619) with videos related to
Sort By:
Pageof 3,462
Cancer|August 1, 1978
Mucinous carcinoma of anal duct origin presenting clinically as a vaginal cystF B Askin, K Muhlendorf, B J WalzCancer|August 1, 1978
Lobular neoplasia (so-called lobular carcinoma in situ) of the breastC D Haagensen, N Lane, R Lattes, et al.Cancer|July 13, 2010
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancerSarah Everitt, Alan Herschtal, Jason Callahan, et al.Cancer|September 15, 1990
Ondansetron for the prevention of emesis induced by high-dose cisplatin. A multi-center dose-response studyA Khojasteh, G Sartiano, E Tapazoglou, et al.Cancer|April 2, 2011
Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program ExperienceFrank Vicini, Joyce Nancarrow-Tull, Chirag Shah, et al.Cancer|April 2, 2011
Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumorAkira Sawaki, Toshirou Nishida, Toshihiko Doi, et al.Cancer|April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancerBen Tran, Scott Kopetz, Jeanne Tie, et al.Cancer|April 2, 2011
Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancerMatthew H Hayn, Heather Orom, Vickie L Shavers, et al.Cancer|April 2, 2011
Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemiaSergej Konoplev, Jeffrey L Jorgensen, Deborah A Thomas, et al.Cancer|April 2, 2011
A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomasWilliam T Couldwell, Amy A Surnock, Alfonso J Tobia, et al.Pageof 3,462